NCT00923533View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2009

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan

Fimasartan (7day) Fimasartan + Hydrochlorothiazide (7day)

DRUG

Hydrochlorothiazide

Hydrochlorothiazide (7day) Fimasartan + Hydrochlorothiazide (7day)

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY